- Conditions
- Intermittent Explosive Disorder
- Interventions
- Endotoxin (E. coli O:113, Reference Endotoxin), Saline (Placebo)
- Biological · Other
- Lead sponsor
- Ohio State University
- Other
- Eligibility
- 21 Years to 55 Years
- Enrollment
- 112 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2026 – 2030
- U.S. locations
- 1
- States / cities
- Columbus, Ohio
Source: ClinicalTrials.gov public record
Updated Mar 26, 2026 · Synced May 22, 2026, 4:27 AM EDT